To detect new antigen candidates for serological tests, we studied the antibody response to pneumococcal protein antigens in mice infected intratracheally with various Streptococcus pneumoniae strains. Sera were tested by Western blotting against whole-cell protein extracts. Mice developed a detectable immunoglobulin G-type response against a small number of polypeptides. The antibody response was strain dependent: sera from individuals infected with the same strain gave similar banding patterns on immunoblots. The banding patterns varied with the strain used for infection. However, a band at 36 to 38 kDa was recognized by all reactive sera. This band appeared to correspond to a polypeptide that was antigenically well conserved among the different S. pneumoniae serotypes. An antibody response to this antigen developed in mice irrespective of the capsular type, the virulence, and the susceptibility to penicillin G of the infecting strain. Thus, this 36-to 38-kDa protein antigen may be of value for the development of a serological test for humans.
Using a Western blot technique, Renneberg et al. recently detected serum antibodies against pneumococcal polypeptides in apparently healthy individuals (18) . The numbers of different polypeptides recognized by these sera were consistent with the levels of antibodies against type-specific polysaccharides and C polysaccharide, suggesting the possible value of this approach for serological analysis. We used a similar Western blot technique to study the antibody response to pneumococcal protein antigens in a murine model of pneumonia. This experimental model has the following advantages. Intratracheal peroral inoculation is highly reproducible. Blood and lung cultures of samples collected 48 h after inoculation allow the degree of infection to be assessed (21) . Comparable antigenic burdens can be obtained irrespective of the intrinsic virulence of the strains by adjusting the dose given to animals. Finally, experimental pneumococcal pneumonia in mice is a good model of primary infection, as mice do not naturally carry S. pneumoniae.
The S. pneumoniae strains used for infecting mice are listed in Table 1 . The other S. pneumoniae strains used in this study, all obtained from the Centre National de Référence des Pneumocoques (Créteil, France), were strains 40492 (serotype 4), 40336 (serotype 7), 40500 (serotype 9V), 40527 (serotype 14) , and 40421 (serotype 18). Strains were stored at Ϫ80°C in brain heart infusion (BHI) broth (BioMérieux, Marcy l'Etoile, France) supplemented with 5% filtered horse serum (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France). The MIC of penicillin G was determined by E-test (BMD, Marne la Vallée, France). The intraperitoneal 50% lethal dose was estimated by the probit method. Groups of eight mice were challenged intraperitoneally with various doses of bacteria, and the mortality rates were monitored for 3 weeks. For infection of mice, pneumococci were grown in BHI broth for 5 to 6 h at 37°C in a 5% CO 2 atmosphere until the optical density at 600 nm reached 0.4. Ten-milliliter aliquots were centrifuged, and the resulting pellets were resuspended in the same volume of phosphate-buffered saline (PBS; pH 7.2). For inoculations, this bacterial suspension was diluted 1:100 in PBS (virulent strains 4241 and 6254) or used undiluted (all other strains). The titers of the inocula were determined by plating 0.1 ml each of serial 10-fold dilutions on Columbia agar containing 5% sheep blood (BioMérieux).
Female Swiss mice (Iffa-Credo Laboratories, St. Germain sur l'Arbresle, France), aged 7 weeks (20 to 22 g each), were infected by the intratracheal peroral route as described in detail elsewhere (6) . Animals were anesthetized intraperitoneally with 0.2 ml of 0.65% sodium pentobarbital (Dolethal; Vetoquinol, Lure, France). They were suspended vertically by placing the upper incisor teeth on a wire hook, with the ventral side of the mouse facing the experimenter. The trachea was then cannulated with a blunt metal needle (23 gauge) by the oral route. The bacterial inoculum was delivered in a volume of 0.05 ml via a Microliter syringe (Hamilton, Reno, Nev.). Mice were kept vertical for 5 min to allow distal alveolar migration of bacteria. Fifteen mice per group were inoculated. Amoxicillin (50 mg/kg of body weight) was administered intraperitoneally 48 and 72 h after pneumococcal inoculation, irrespective of the susceptibility of the infecting strain to penicillin G. Blood and lung cultures were initiated 48 h after bacterial inoculation, before amoxicillin injection. Five mice per group were sacrificed by cervical dislocation. The thorax was opened, and heart blood was collected and cultured for 18 h at 37°C in BHI broth. Cultures turbid to the naked eye were considered positive and were subcultured to confirm the presence of pneumococci. The lungs were dissociated from the trachea and other structures and homogenized in 1 ml of PBS. Bacterial titers were determined by plating 0.1 ml each of serial 10-fold dilutions of the homogenates on Columbia agar.
Western blots were prepared as follows. Bacteria were grown in BHI for 15 h at 37°C in a 5% CO 2 atmosphere. Ten-milliliter cultures were centrifuged, and the resulting pellets were washed once in PBS and resuspended in 500 l of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (100 mM Tris-HCl [pH 6.8], 2% SDS, 5% 2-mercaptoethanol, 10% sucrose, 0.01% bromophenol blue). SDS-PAGE was carried out as described by Laemmli (11) in 11% polyacrylamide minigels (Mini Protean II; BioRad, Ivry sur Seine, France). Protein concentrations were measured by the method of Bradford Blood samples to be analyzed were obtained by retro-orbital puncture (individual kinetics of antibody response) or heart puncture. After centrifugation, serum samples were stored at Ϫ80°C until use. Antipneumococcal antibodies were detected by probing the Western blots with the sera. Immunoglobulin G (IgG) was removed from the sera prior to IgM detection with protein G columns (HITRAP columns; Pharmacia Biotech, Orsay, France). The nitrocellulose membranes were first blocked by incubation with washing buffer (0.15% Tween 20 in PBS [pH 7.2]) containing 5% skim milk for 1 h at room temperature. The membranes were then incubated for 45 min at room temperature with murine serum samples diluted 1:100 (IgG) or 1:10 (IgM). After being washed, the membranes were incubated with peroxidase-conjugated goat anti-mouse IgG or IgM (Organon Teknika, West Chester, Pa.) for 45 min at room temperature. All sera and labeled antibody dilutions were prepared in washing buffer containing 5% skim milk. Antibody binding was revealed by adding 0.05% diaminobenzidine-tetrahydrochloride (Sigma) and 0.03% hydrogen peroxide. No antipneumococcal response was detected in serum samples obtained from noninfected control mice. Antibody response to inoculation with strain 4241 at a dose of 5 ؋ 10 5 CFU/mouse. Strain 4241 (serotype 3) was tested first because its behavior in the mouse pneumonia model is well documented (1, 21) . Mice were inoculated by the intratracheal route with 5 ϫ 10 5 CFU per animal, a dose at which strain 4241 has been reproducibly shown to cause pneumonia with bacteremia in Swiss mice (21) . Blood was collected by retro-orbital puncture on days 0, 3, 10, 16, and 30, and sera were tested by Western blotting for the presence of IgM and IgG antibodies against crude protein extracts prepared from strain 4241.
A group of 15 mice was challenged. The five mice sacrificed on day 2 were all bacteremic, and the bacterial count in their lungs (mean log 10 CFU Ϯ standard deviation) was 6.9 Ϯ 1.1. Of the 10 mice kept for analysis of the antibody response, 5 survived until completion of the study protocol. The IgG-type responses were similar in all five. No response was observed until day 10, when the sera recognized two bands at 37 and 75 kDa (Fig. 1) . On days 16 and 30, these bands became much stronger, while several fainter bands appeared at 40, 46, 48, and 66 kDa. Overall, the sera recognized very few polypeptides. No IgM-type response was detected in any of the mice tested.
Dose-response effect in mice challenged with strain 4241. Groups of 15 mice were challenged with various doses of strain 4241 (5 ϫ 10 2 to 5 ϫ 10 5 CFU per animal). Five mice per group were killed on day 2. The results of the blood and lung cultures for these animals are shown in Table 2 .
Blood was collected on days 10 and 16 from five animals per group and on day 30 from all the animals still living. Only the IgG-type response was studied. No response to the smallest inoculum (5 ϫ 10 2 CFU per mouse) was detected at any time. Mice inoculated with 5 ϫ 10 4 or 5 ϫ 10 3 CFU did not develop detectable responses until day 30. The reactivities of sera collected at this time from mice inoculated with 5 ϫ 10 3 , 5 ϫ 10 4 , or 5 ϫ 10 5 CFU are shown in Fig. 2 . Three of four, two of four, and four of four serum samples obtained from mice inoculated with, respectively, doses of 5 ϫ 10 3 , 5 ϫ 10 4 , and 5 ϫ 10 5 CFU gave positive reactions. Interestingly, the patterns of response were similar with the three doses. As previously found, the strongest response was directed against a 37-kDa polypeptide. Fainter bands were detected at 40, 48, 75, and Ͼ90 kDa.
Antibody response after infection with various S. pneumoniae strains. Using the same murine model of pneumonia, we studied the IgG-type responses induced by S. pneumoniae strains of various serotypes and with various susceptibilities to penicillin G and intrinsic virulences ( Table 1) . Groups of 15 mice were each challenged with a different strain. The infecting dose was adjusted according to the virulence of the strain so that similar bacterial burdens were obtained: on day 2, the mean bacterial counts in the lungs (for five mice per group) were between 4.5 and 5.5 log 10 CFU for all strains (Table 3) . Sera collected on day 30 were analyzed by Western blotting with the infecting strain as the source of protein antigens (Fig.  3) . Serum samples diluted 1:100 from surviving animals (4 to 10 mice) were tested for each strain. Strains 26772, 60600, 15986, and 54988 elicited detectable IgG-type responses in most animals. Sera from mice challenged with the same strain gave similar staining patterns. The response was strain dependent: the banding patterns varied according to the infecting strain. However, for all infecting strains, sera consistently gave positive signals at 36 to 38 kDa. In most cases, the band detected at this position was the most pronounced. Serum samples from mice challenged with strain 6254 were negative at a dilution of 1:100 (not shown). At a dilution of 1:20, antipneumococcal IgGs were detected in one of four mice (Fig. 3) . Again, the strongest response was directed against a 36-to 38-kDa polypeptide.
Recognition of conserved antigens by sera. We studied whether the antigens recognized by the sera, especially the 36-to 38-kDa antigen, were type specific. For this purpose, immunoblots of protein extracts prepared from a panel of S. pneumoniae strains belonging to the most common serotypes were probed with sera obtained on day 30 of infection with strains 4241, 26772, 60600, 6254, and 15986. Each serum gave similar banding patterns with all antigenic preparations (Fig. 4) . In particular, the 36-to 38-kDa antigen was recognized in all cases. This suggests that the antibodies elicited in the animals reacted with antigens found in all of the serotypes tested.
In the model of pneumonia used in this study, mice developed detectable antibody responses against a small number of pneumococcal polypeptides. Sera collected 30 days postinfection gave a maximum of four or five strong bands on immunoblots, irrespective of the infecting strain. This contrasted with the large number of polypeptides stained by Coomassie brilliant blue after separation of the pneumococcal extracts by SDS-PAGE. Although outbred mice were used in this study, sera from animals challenged with a given S. pneumoniae strain gave very similar banding patterns on immunoblots. The banding patterns varied substantially among the strains. Thus, in the murine model of pneumonia, the antibody response to pneumococcal proteins appears to be strain dependent. However, sera from mice infected with one S. pneumoniae strain showed strong cross-reactivity with extracts of S. pneumoniae strains of other serotypes. This suggests that most antipneumococcal antibodies elicited during murine infection recognize well-conserved protein antigens. Rennenberg et al. also found a considerable degree of similarity in the banding patterns when using a given human serum to probe protein extracts from S. pneumoniae strains of different serotypes (18) . This is consistent with previous studies showing that most S. pneumoniae protein antigens are common to the different capsular serotypes (16) .
Among the polypeptides recognized by the sera, a polypeptide with an apparent mobility of 36 to 38 kDa might be particularly useful as a diagnostic antigen. An antibody response to this polypeptide developed in all mice, irrespective of the capsular type, the virulence, and the susceptibility to penicillin G of the infecting strain. This response was the earliest and, for most strains, the strongest that was observed. Antibodies elicited after infection with one strain recognized a 36-to 38-kDa polypeptide in the antigenic extracts prepared from S. pneumoniae strains of the most common serotypes. Thus, this 36-to 38-kDa polypeptide appears to be both strongly immunogenic and highly conserved among the different S. pneumoniae serotypes. Two other findings suggest that this polypeptide may be suitable for serological tests with humans. First, the antibody response to the 36-to 38-kDa polypeptide was not abrogated by early antibiotic treatment. Second, the response was detectable with small bacterial burdens in the lungs. The 36-to 38-kDa polypeptide remains to be identified. However, it may be the pneumococcal protein PsaA, whose gene has been recently cloned and sequenced (20) . PsaA is a 37-kDa adhesin present in virtually all S. pneumoniae strains (19) . It is probably exposed on the pneumococcal surface (19) and therefore may be a preferred target for the humoral immune response in infected hosts. Alternatively, the 36-to 38-kDa polypeptide may be the pneumococcal autolysin LytA, whose molecular mass is 35 to 36 kDa (8) , or a previously undescribed protein.
There are some limitations to this study. First, we used crude bacterial extracts as antigenic preparations and consequently may not have detected antibodies against pneumococcal proteins present in small amounts in these extracts. This is probably why we did not find an antibody response against a 53-kDa antigen that could correspond to the pneumococcal toxin pneumolysin (2) . Secondly, we detected IgG-but not IgM-type antipneumococcal antibodies. This is unlikely to be due to the inability of mice to mount an IgM-type antibody response to pneumococcal antigens. A recent study reported that mice as young as 2 weeks old produced antipneumococcal IgM antibodies (13) . Possibly, the Western blot technique may fail to reveal low levels of IgM-type antibodies. Other techniques, for example, immunocapture assays, are much better suited to the detection of IgMs. Third, the local immune response is potentially important in pneumococcal pneumonia. This fact should be considered in future studies. Finally, the antibody response to pneumococcal infection may be different in humans. We are currently assessing the relevance of our findings for humans.
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